Analysen von Andrew Baum
| 28.05.14 | Bayer buy | Citigroup Corp. | |
| 20.05.14 | AstraZeneca buy | Citigroup Corp. | |
| 19.05.14 | AstraZeneca buy | Citigroup Corp. | |
| 25.04.14 | AstraZeneca buy | Citigroup Corp. | |
| 22.04.14 | AstraZeneca buy | Citigroup Corp. | |
| 25.01.11 | AstraZeneca overweight | Morgan Stanley | |
| 25.01.11 | Novartis overweight | Morgan Stanley | |
| 15.12.10 | AstraZeneca overweight | Morgan Stanley | |
|
Werbung
|
|||
| 01.12.10 | Novartis overweight | Morgan Stanley | |
| 12.11.10 | Novartis overweight | Morgan Stanley | |
| 19.10.10 | Novo Nordisk overweight | Morgan Stanley | |
| 23.09.10 | Novartis overweight | Morgan Stanley | |
| 15.09.10 | Novo Nordisk overweight | Morgan Stanley | |
| 02.09.10 | AstraZeneca overweight | Morgan Stanley | |
| 17.08.10 | EGIS Pharmaceuticals overweight | Morgan Stanley | |
| 07.07.10 | Novartis kaufen | Morgan Stanley | |
| 30.06.10 | AstraZeneca kaufen | Morgan Stanley | |